Back to Search
ANDREW MILLER, MD
MD
Anesthesiology Physician
NPI: 1851307722IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
MD00042072(WA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Class of 1999
Clinical Trials (4)
4
Linked Trials
0
Recruiting
4
With Results
A Study of Infliximab for Treatment Resistant Major Depression
NCT00463580COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
NCT04352101COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
NCT02796755COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
NCT00352885COMPLETEDPHASE4STUDY_CHAIR
Research & Publications (20)
Antidepressants for the treatment of depression in people with cancer.
PMID 36999619·Cochrane Database Syst Rev·2023
6-review
Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
PMID 25529904·Brain Behav Immun·2015
2-rct
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
PMID 23624296·Brain Behav Immun·2013
2-rct
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
PMID 23575741·Neuropsychopharmacology·2013
2-rct
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
PMID 22945416·JAMA Psychiatry·2013
4-observational
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
PMID 22353759·Neuropsychopharmacology·2012
4-observational
The Nanoparticle Information Library (NIL): a prototype for linking and sharing emerging data.
PMID 17924276·J Occup Environ Hyg·2007
8-other
Role of lubrication oil in particulate emissions from a hydrogen-powered internal combustion engine.
PMID 17969702·Environ Sci Technol·2007
8-other
Real-time estimation of elemental carbon emitted from a diesel engine.
PMID 17874787·Environ Sci Technol·2007
8-other
Generation of a novel system for studying spleen tyrosine kinase function in macrophages and B cells.
PMID 19124742·J Immunol·2009
7-preclinical
Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.
PMID 19255312·J Clin Oncol·2009
3-trial
Pediatric cardiopulmonary bypass circuits: a review of studies conducted at the Penn State Pediatric Cardiac Research Laboratories.
PMID 19361042·J Extra Corpor Technol·2009
6-review
Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: quantification of migration by a novel near-infrared method.
PMID 19053059·Glia·2009
7-preclinical
Shellfish face uncertain future in high CO2 world: influence of acidification on oyster larvae calcification and growth in estuaries.
PMID 19478855·PLoS One·2009
7-preclinical
Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles of ob/ob mice.
PMID 18768766·Am J Physiol Regul Integr Comp Physiol·2008
7-preclinical
Identification of the myelin protein plasmolipin as the cell entry receptor for Mus caroli endogenous retrovirus.
PMID 18463156·J Virol·2008
7-preclinical
Hyaluronidase 2 and its intriguing role as a cell-entry receptor for oncogenic sheep retroviruses.
PMID 18485731·Semin Cancer Biol·2008
6-review
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).
PMID 18827613·J Thorac Oncol·2008
3-trial
CB2 receptor-mediated migration of immune cells: it can go either way.
PMID 17982478·Br J Pharmacol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 104 WEST 5TH AVE, SUITE 230E
SPOKANE, WA 99204 - Phone
- (509) 838-8828
Quick Facts
- NPI
- 1851307722
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile